Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for BioCorRx (BICX) over the last 15 years, with Q3 2025 value amounting to $71987.0.

  • BioCorRx's Depreciation & Amortization (CF) rose 97203.28% to $71987.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $181810.0, marking a year-over-year increase of 57695.57%. This contributed to the annual value of $33145.0 for FY2024, which is 2363.85% up from last year.
  • As of Q3 2025, BioCorRx's Depreciation & Amortization (CF) stood at $71987.0, which was up 97203.28% from $71977.0 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Depreciation & Amortization (CF) registered a high of $71987.0 during Q3 2025, and its lowest value of $6665.0 during Q1 2023.
  • Over the past 5 years, BioCorRx's median Depreciation & Amortization (CF) value was $6863.0 (recorded in 2021), while the average stood at $16870.4.
  • As far as peak fluctuations go, BioCorRx's Depreciation & Amortization (CF) plummeted by 6524.71% in 2021, and later surged by 97204.35% in 2025.
  • Over the past 5 years, BioCorRx's Depreciation & Amortization (CF) (Quarter) stood at $6863.0 in 2021, then dropped by 0.01% to $6862.0 in 2022, then decreased by 2.14% to $6715.0 in 2023, then surged by 93.64% to $13003.0 in 2024, then soared by 453.62% to $71987.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $71987.0 for Q3 2025, versus $71977.0 for Q2 2025 and $24843.0 for Q1 2025.